Straumann Holding Ag · SIX:STMN
Straumann — Q1 2013 Earnings Presentation
12 slides from Straumann's earnings presentation, Apr 30, 2013
Slide 1: 2013 First-quarter results
2013 First-quarter results Analysts’ & Media Conference Call Basel, 30 April 2013 Disclaimer This presentation contains certain “forward-looking statements”, which can be identified by the use of terminology such as “will”, “guidance”, “would”, “prevailing”, “still be able to”, “should”, “confidence
Slide 2: Highlights: What is happening in the market?
Highlights Marco Gadola CEO What is happening in the market? No improvement in economic Global dental implant market (2012: ~CHF 3bn) environment or consumer sentiment in Europe and major Asian markets ccccccccccccccccc cccccccccc Emerging markets continue to perform 68-70% ~61% well Value & l
Slide 3: Straumann's response and Q1 2013 highlights
Straumann’s response Investment focus on high-growth markets Solutions to reduce overall treatment costs and lab equipment investments (CARES Scan & Shape service) Penetrate value segment by leveraging Neodent and exploring commercial approaches within existing portfolio Expand the reach & a
Slide 4: Business performance
Business performance Thomas Dressendörfer CFO Tough environment in Europe hinders return to growth in CHF m (5.6%) in CHF -0.2 -1.7 (4.7%) in -8.1 organic +0.9 -1.0 -0.2 185.1 183.2 Change organic 174.8 (-0.1%) (0.8%) (7.7%) +2.1% (4.4%) (2.6%) Q1 revenue FX Effect iTero Effect Q1 revenue Europe Nor
Slide 5: North America and Europe regional performance
Regeneratives outpace replacement and restorative businesses Implants Restoratives Regeneratives Straumann 9 Growth intact in N. America; Europe struggles further Revenue change organic Revenue contracts 8% (l.c. and organic) Europe 56% Weak consumer sentiment slows region -5.3% -6.3% Stiff
Slide 6: Asia Pacific and Rest of World; bond placement
APAC slows while RoW picks up Revenue change organic 4% contraction in l.c. Asia Pacific 4.2% Japan: perception of implant 56% dentistry tarnished by media and -1.0% will take time to restore -2.4% -4.4% Solid performances in China and 13% Australia Q2 2012 Q3 2012 Q4 2012 Q1 2013 3% contrac
Slide 7: Shaping the future
Shaping the future Multiple enhancements to save treatment time and cost launched at IDS and Chicago Midwinter CARES Scan & Shape CARES System 8.0 CARES X-Stream SFI Anchor Full-contour Indication-Based Loxim implant Sterile healing zirconia zerion Product Selection transfer piece HT Guide © Strauma
Slide 8: Resizing for a changed market
Resizing for a changed market ≈140 Current organization built 2575 based on ‘bullish’ market 2517 2452 2434 ≈200 growth expectations, which 2361 have not materialized 2230 In view of current developments and mid-term economic outlook, today’s staff level and cost base are no longer sustainable
Slide 9: Organizational structure and Outlook
Organizational structure simplified and adapted to focus more on customer needs and solutions Executive Management Board (as of May 2013) Marco Gadola Guillaume Daniellot Wolfgang Becker Andy Molnar Dr Alexander Ochsner CEO Sales Western Europe Sales Central Europe Sales North America Sales APAC & L
Slide 10: Questions?
Questions? Calendar of upcoming corporate events 30 April Q1 sales Webcast 20 August Q2 sales and H1 results Basel, Conference 31 October Q3 sales Webcast Detailed calendar on www.straumann.com Straumann 20 10
Slide 11: Your contacts; Net revenue growth Q1 2013
Your contacts Fabian Hildbrand Corporate Investor Relations Phone +41 (0)61 965 13 27 Mobile +41 (0)79 392 80 32 Email fabian.hildbrand@straumann.com Mark Hill Thomas Konrad Corporate Communications Phone +41 (0)61 965 13 21 Phone +41 (0)61 965 15 46 Email mark.hill@straumann.com Email thomas.konrad
Slide 12: Currency impact to neutralize throughout the year
Currency impact to neutralize throughout the year Revenue breakdown 2012 Average exchange rates (rounded) CHF 11% FY 2011 FY 2012 EURCHF 1.23 1.21 Other EUR 21% 41% USDCHF 0.89 0.93 JPYCHF 1.11 1.17 Straumann’s major exchange rates since 2012 (indexed to 100) USD/CAD/AUD 27% 110 Cost breakdown 20121